Aminolean
Aminolean, licence 80077298: inactive licence in Health Canada data. The French and European references below do not constitute authorisation for sale in France or an assessment of safety or efficacy.
Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks, retrieved 27 October 2026.
Contains information licensed under the Open Government Licence – Canada (Health Canada, LNHPD)
Licence du gouvernement ouvert – Canada 2.0 (OGL-Canada 2.0)
Natural health product licensed in Canada
- Licence holder
- RSP Nutrition
- NPN or DIN-HM
- 80077298
- Status
- Inactive licence
- Licence date
- 9 May 2017
- Revision date
- Not provided
- Form
- Poudre
- Route of administration
- Orale
- Application type
- Non traditionnelle
If this product were sold in France
- Conditions légales
Contains tea (Camellia sinensis). Green tea extracts must provide less than 800 mg of epigallocatechin-3-gallate per daily portion, with mandatory warnings.
annexe III, partie B (règlement (UE) 2022/2340). Regulation (EC) No 1925/2006, latest consolidated version, retrieved 21 October 2026.
- Conditions légales
Camellia sinensis (L.) Kuntze: Seules sont admises la poudre issue du broyage des feuilles et les préparations obtenues à partir des solvants suivants : l'eau, l'alcool à 25 % (v/v), ainsi que les solvants autorisés pour la décaféination ou la suppression des matières irritantes et amères. Les recommandations d'emploi ne doivent pas conduire à une ingestion quotidienne d'EGCG supérieure à 300 mg. L'étiquetage doit comporter des avertissements déconseillant leur prise en dehors des repas, ainsi que leur consommation par les enfants, les adolescents, les femmes enceintes ou allaitantes.
arrêté du 24 juin 2014, annexe I. French orders of 9 May 2006 (nutrients), 24 June 2014 (plants) and 26 September 2016 (other substances), consolidated LEGI collection, retrieved 23 October 2026.
A daily quantity is calculated only for an explicit adult oral dosage, stated per day and in a solid unit matching the product form. Ambiguous units, liquids, powders and paediatric doses are not extrapolated. A quantity not calculated is not compared with dose limits. This analysis does not constitute authorisation for sale in France or an assessment of safety or efficacy.
Composition
| Medicinal ingredient and source | Per dosage unit, according to the source | Maximum per day, adult |
|---|---|---|
| Acide (S)-2,6-diaminohexanoïque Source : L-Lysine | 25.0 milligramme | Not calculated |
| Acide (S)-2-amino-4-(méthylthio)butanoïque Source : L-méthionine | 1.0 milligramme | Not calculated |
| L-Phénylalanine Source : L-phénylalanine | 25.0 milligramme | Not calculated |
| L-Valine Source : L-valine | 262.5 milligramme | Not calculated |
| (S)-N5-Carbamoylornithine Source : Citrulline | 150.0 milligramme | Not calculated |
| Acide (2S,3S)-2-amino-3-méthylpentanoïque Source : L-isoleucine | 262.5 milligramme | Not calculated |
| Acide (S)-2-amino-4-méthylpentanoïque Source : L-Leucine | 375.0 milligramme | Not calculated |
| L-Histidine Source : L-Histidine | 25.0 milligramme | Not calculated |
| Acide 2-aminoéthanesulfonique Source : Taurine | 3000.0 milligramme | Not calculated |
| Acide (S)-2,5-diamino-5-oxopentanoïque Source : L-Glutamine | 200.0 milligramme | Not calculated |
| Acide (S)-2-amino-5-[(aminoiminométhyl)amino]pentanoïque Source : L-arginine | 150.0 milligramme | Not calculated |
| Acide 3-aminopropionique Source : Beta-alanine | 449.0 milligramme | Not calculated |
| Acide (S)-alpha-amino-4-hydroxybenzènepropanoïque Source : L-Tyrosine | 50.0 milligramme | Not calculated |
| Acide (2S,3R)-2-amino-3-hydroxybutyrique Source : L-thréonine | 25.0 milligramme | Not calculated |
| 3,7-dihydro-1,3,7-triméthyl-1H-purine-2,6-dione Source : Camellia sinensis - feuille | 125.0 milligramme | Not calculated |
| Camellia sinensis Source : Feuille Extract : Matériel brut sec Extraction ratio : 20:1 Dry plant equivalent : 100 milligramme Potency : 50.0 % Epigallocatechin 3-gallate | 5.0 milligramme | Not calculated |
| Camellia sinensis Source : Feuille Potency : 0.25 % Caffeine | Not specified | Not calculated |
| Extrait de fève de café vert Source : Coffea arabica graine Extract : Matériel brut sec Extraction ratio : 4:1 Dry plant equivalent : 20 milligramme | 5.0 milligramme | Not calculated |
| Acide linoléique conjugué Source : Acide linoléique conjugué | 745.0 milligramme | Not calculated |
| Sel interne de (2R)-2-(Acétyloxy)-3-carboxy-N,N,N-triméthyl-1-propanaminium Source : Acétyl-L-Carnitine | 745.0 milligramme | Not calculated |
Non-medicinal ingredients
Carraghénine, Sucralose, Dioxyde de silicium, Acide citrique, Saveur de citron-lime, Jaune 5, Gomme de xanthane, Acide DL-malique, Rouge 40, Acésulfame-K, Saveur de melon d'eau, Bleu 1, Gomme de cellulose, Saveur de punch aux fruits, Saveur de grenade, Silicate de calcium, Saveur de mûre
Recommended doses in Canada
| Population | Age | Quantity per serving | Frequency |
|---|---|---|---|
| Adultes | Not specified | 1.0 Portion(s) | 1.0 Tous les jours |
Uses authorised in Canada
Text supplied in English because no French text is available.
Workout Supplement. Athletic support. Source of essential amino acids involved in muscle protein synthesis. Assists in the building of lean muscle [tissue/mass] when combined with regular [weight/resistance] training and a healthy balanced diet. Source of branched chain amino acids (BCAAs), which are involved in protein synthesis. Helps (temporarily) to promote alertness and wakefulness, and to enhance cognitive performance. Helps (temporarily) to relieve fatigue, to promote endurance, and to enhance motor performance. Source of antioxidants for the maintenance of good health.
A use authorised in Canada is not an authorised health claim in the European Union. See the health claims register.
Warnings in Canada
- Effets indésirables connus
May cause a flushing, tingling and/or prickling sensation of the skin, in which case, reduce the dose. Hypersensitivity/allergy is known to occur, in which case, discontinue use. May cause digestive problems.
- Précautions et mises en garde
Consult a health care practitioner prior to use if you are pregnant or breastfeeding. Consult a health care practitioner prior to use if you are following a low protein diet. Ensure to drink enough fluid before, during, and after exercise. Consult a health care practitioner prior to use if you are taking lithium. Consult a health care practitioner prior to use if you have high blood pressure, glaucoma, and/or detrusor instability (overactive bladder syndrome). Consumption with natural health products (e.g. bitter orange extract, synephrine, octopamine, ephedra) or other drugs (e.g. ephedrine) which increase blood pressure is not recommended. Consumption with other caffeine-containing products (e.g. medications, coffee, tea, colas, cocoa, guarana, maté) is not recommended. This product is not intended as a substitute for sleep. Consult a health care practitioner prior to use if you have a liver disorder or develop symptoms of liver trouble (such as abdominal pain, dark urine or jaundice). Consult a health care practitioner prior to use if you have an iron deficiency. If you have liver disease, kidney disease and/or a seizure disorder, consult a health care practitioner prior to use.
Source
Official Health Canada record, licence 80077298
The formula sold in Europe under the same name may differ. This information does not replace advice from a doctor or pharmacist.
The evidence date of this ingredient list is unknown.
Has the product changed? Photograph the packaging.